Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Health Catalyst, Inc.    HCAT

HEALTH CATALYST, INC.

(HCAT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Catalyst to Announce Third Quarter 2020 Operating Results and Host Conference Call on Tuesday, November 10, 2020

10/26/2020 | 03:05pm EST

SALT LAKE CITY, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2020 third quarter operating results on Tuesday, November 10, 2020, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Conference Call Details

The conference call can be accessed by dialing 1-877-295-1104 for U.S. participants, or 1-470-495-9486 for international participants, and referencing participant code 7195951. A live audio webcast will be available online at https://ir.healthcatalyst.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Health Catalyst Investor Relations Contact:

Adam Brown
Senior Vice President, Investor Relations
+1 (855)-309-6800
ir@healthcatalyst.com

Health Catalyst Media Contact:

Amanda Hundt
+1 (575)-491-0974
amanda.hundt@healthcatalyst.com

 

Primary Logo


© GlobeNewswire 2020
All news about HEALTH CATALYST, INC.
01/26HEALTH CATALYST : How Activity-Based Costing Can Boost Hospital Finances (Becker..
PU
01/26HEALTH CATALYST : Business Elevated Podcast Interview with Dan Orentstein (Utah ..
PU
01/19BUSINESS RADIO X : Trudy Sullivan Interview
PU
01/18HEALTH CATALYST : Becker's Healthcare CEO + CFO Forum
PU
01/13HEALTH CATALYST : Named a Glassdoor Best Places to Work for the Fourth Time in S..
PU
01/13HEALTH CATALYST : Re-Certified as a Great Place to Work Company
PU
01/07HEALTH CATALYST : Data Bridge the Knowledge Gaps in the Fight Against COVID-19
PU
01/07TRANSFORMATION CAPITAL : Launches $500 Million Digital Health Fund to Support En..
PR
2020Health Catalyst to Participate in Upcoming Investor Conference
GL
2020HEALTH CATALYST : Utah Companies Recognized for Leadership, Training and Creativ..
PU
More news
Financials (USD)
Sales 2020 188 M - -
Net income 2020 -91,8 M - -
Net cash 2020 96,9 M - -
P/E ratio 2020 -21,2x
Yield 2020 -
Capitalization 2 166 M 2 166 M -
EV / Sales 2020 11,0x
EV / Sales 2021 9,24x
Nbr of Employees 1 000
Free-Float 95,1%
Chart HEALTH CATALYST, INC.
Duration : Period :
Health Catalyst, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HEALTH CATALYST, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Average target price 44,85 $
Last Close Price 50,96 $
Spread / Highest target -1,88%
Spread / Average Target -12,0%
Spread / Lowest Target -27,4%
EPS Revisions
Managers and Directors
NameTitle
Daniel D. Burton Chief Executive Officer & Director
Patrick J. Nelli President
Paul Horstmeier Chief Operating Officer
Bryan Hunt Chief Financial Officer
Holly Rimmasch Chief Clinical Officer
Sector and Competitors
1st jan.Capitalization (M$)
HEALTH CATALYST, INC.17.07%2 166
THERMO FISHER SCIENTIFIC11.39%201 271
DANAHER CORPORATION5.33%166 214
INTUITIVE SURGICAL, INC.-5.92%90 477
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.14.55%85 238
ILLUMINA, INC.13.66%61 400